Alamar Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ALMR Nasdaq 2836 alamarbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alamar Biosciences, Inc.

Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq - Aug 6th, 2026 4:46 am
Attovia adds to biotech IPO momentum with $289M offering - Aug 5th, 2026 6:05 am
Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome - Jul 28th, 2026 2:12 pm
ALZpath Broadens Strategic Agreement with Alamar Biosciences to Advance Clinical Diagnostics for Alzheimer's Disease - Jul 23rd, 2026 6:30 am
Braveheart, Attovia join next wave of biotech IPOs - Jul 15th, 2026 5:34 am
Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026 - Jul 14th, 2026 2:05 pm
Alamar Hits A High Note On Alzheimer's Buzz - Jul 13th, 2026 2:50 pm
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases - Jul 13th, 2026 12:30 am
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling - Jul 10th, 2026 4:11 am
Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research - Jul 7th, 2026 7:12 am
Cathie Wood Doubles Down on AI, Loads Up on Tesla, Palantir, and SpaceX - Jul 1st, 2026 7:04 am
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - Jun 23rd, 2026 9:27 am
Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics - Jun 2nd, 2026 12:43 pm
Evaluating Alamar Biosciences (ALMR) Valuation As Shares Show Modest Year To Date Gains - May 14th, 2026 8:10 am
Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls - May 12th, 2026 7:56 am
Alamar Biosciences Reports First Quarter 2026 Financial Results - May 8th, 2026 6:00 am
Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference - May 5th, 2026 2:05 pm
Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ - Apr 20th, 2026 1:09 am